| Category | FY | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NIAID
|
5R01AI072204-08
|
|
Cervical, Anal & Oral HPV Persistence/Adolescent Girls
|
DIAZ, ANGELA
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
NY
|
$1,253,871
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NIAID
|
5R01AI104709-03
|
|
Epidemiologic Impact of HPV Vaccination
|
KAHN, JESSICA
|
CINCINNATI CHILDRENS HOSP MED CTR
|
OH
|
$672,714
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NIAID
|
5K01AI106961-02
|
|
A Practice-Provider-Parent-Adolescent intervention to increase HPV vaccination
|
BEDNARCZYK, ROBERT
|
EMORY UNIVERSITY
|
GA
|
$117,855
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NICHD
|
5K23HD068394-04
|
|
Social Network Influences on Values Related to Parental HPV Vaccine Refusal
|
FU, LINDA
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$125,010
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
FIC
|
5D43TW009606-03
|
|
Haiti Research Training Program in the Prevention of AIDS Cervical Cancer
|
FITZGERALD, DANIEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$23,204
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5D43TW009606-03
|
|
Haiti Research Training Program in the Prevention of AIDS Cervical Cancer
|
FITZGERALD, DANIEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$250,000
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5R01CA169093-03
|
|
Using comparative effectiveness analyses to optimize cervical cancer screening
|
SAWAYA, GEORGE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$546,158
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5R01CA047622-22
|
|
Papillomavirus Host Interation
|
CHRISTENSEN, NEIL
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$312,621
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5R01CA118790-07
|
|
Mechanisms of Papillomavirus Neutralization
|
RODEN, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$291,600
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5R21CA178592-03
|
|
HPV Vaccination among Low-Income Hispanic Adolescents
|
GEREND, MARY
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
IL
|
$118,909
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5R01CA154549-04
|
|
Increasing HPV Vaccine Uptake in a Low Income Ethnic Minority Population
|
BASTANI, ROSHAN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$556,313
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5R01CA160744-04
|
|
Comparative and Cost-Effectiveness of Preventing HPV-Related Diseases
|
KIM, JANE
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
MA
|
$308,121
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NIAID
|
1R01AI115983-01
|
|
Immune mediators associated with HPV clearance as predictors of HIV acquisition
|
LIEBENBERG, LENINE
|
CENTRE/AIDS PROGRAMME/RES/SOUTH AFRICA
|
SO AFR
|
$147,073
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5R01CA178414-03
|
|
Developing a self-persuasion intervention promoting adolescent HPV vaccination
|
TIRO, JASMIN
|
UT SOUTHWESTERN MEDICAL CENTER
|
TX
|
$380,799
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NIMHD
|
5P60MD000502-13
|
5565
|
HPV Vaccination among Daughters of Latina Immigrants
|
SCARINCI, ISABEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$290,098
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NIAID
|
5R43AI112421-02
|
|
Therapeutic/preventive vaccination against MusPV
|
CHANG, YUNG
|
PAPIVAX, LLC
|
MD
|
$295,392
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5R01CA172742-02
|
|
HPV E6 and NFX1-123 in differentiation, cell regulation, and cancer
|
KATZENELLENBOGEN, RACHEL
|
SEATTLE CHILDREN'S HOSPITAL
|
WA
|
$402,550
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5R01CA114425-09
|
|
Enhancing HPV-16 E6/E7 Specific Antitumor Immunity
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$303,371
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
1R21CA194831-01
|
|
Increasing HPV Vaccine Coverage among Young Adult Gay and Bisexual Men
|
REITER, PAUL
|
OHIO STATE UNIVERSITY
|
OH
|
$215,075
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NIAID
|
5U19AI113187-02
|
6778
|
Discovery and Refinement of Preventive STI Vaccines Targeting Critical Epitopes o
|
CHACKERIAN, BRYCE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
NM
|
$322,749
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NIAID
|
5U19AI113187-02
|
6780
|
Population-Based Impact of HPV Vaccination and Cervical Screening on Sexually Tra
|
WHEELER, COSETTE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
NM
|
$528,562
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NICHD
|
1R15HD081364-01A1
|
|
Efficacy Trial of a Brief Parent-Based Adolescent Sexual Health Intervention
|
SANTA MARIA, DIANE
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$462,000
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
1R01CA187707-01A1
|
|
State Immunization Information Systems to Improve HPV Vaccination Rates
|
SZILAGYI, PETER
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$644,782
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5U54CA164336-05
|
5331
|
Comparative Effectiveness of the Cervical Cancer Screening Process: Past, Present
|
WHEELER, COSETTE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
NM
|
$316,789
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5U54CA164336-05
|
6137
|
LEADERSHIP/ADMIN CORE
|
WHEELER, COSETTE
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
NM
|
$38,090
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5R01CA157469-05
|
|
Cytology vs at home HPV screening for detection of CIN 2,3,CIS
|
KIVIAT, NANCY
|
UNIVERSITY OF WASHINGTON
|
WA
|
$580,766
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NICHD
|
5R01HD073972-04
|
|
Human Papillomavirus Infection in Perinatally HIV-infected Adolescents in Asia
|
SOHN, ANNETTE
|
FOUNDATION FOR AIDS RESEARCH
|
NY
|
$630,624
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
1R43CA192437-01A1
|
|
Feasibility of a Smartphone Kiosk intervention to increase HPV vaccination
|
HOPFER, SUELLEN
|
REAL PREVENTION, LLC
|
NJ
|
$222,982
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NICHD
|
1R41HD082901-01A1
|
|
Smartphone Technology for Parents and Teens: Improving Vaccination Uptake
|
WOODALL, W
|
KLEIN BUENDEL, INC.
|
CO
|
$224,998
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NIAID
|
5R01AI113305-02
|
|
Normalizing preteen HPV vaccination with practice-based communication strategies
|
CATES, JOAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$583,393
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5K01CA181437-03
|
|
A Text Message Intervention to Increase HPV Vaccine Completion in Young Latinas
|
RONCANCIO, ANGELICA
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$135,621
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5U54CA163066-05
|
8675
|
PILOT PROJECT #2
|
HULL, PAMELA
|
TENNESSEE STATE UNIVERSITY
|
TN
|
$26,308
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5K01CA155417-05
|
|
An HPV Health Communication Randomized Controlled Trial Intervention
|
WALLINGTON, SHERRIE
|
GEORGETOWN UNIVERSITY
|
DC
|
$131,741
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NIGMS
|
5R01GM105033-03
|
|
Narratives in the Informational Patient Society and their Association with Health
|
ROYCHOWDHURY, VWANI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$379,921
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5U54CA163069-05
|
8613
|
Increasing HPV Vaccine Utilization Among African-Amerian Girls Through Social Marketing
|
SANDERSON, MAUREEN
|
MEHARRY MEDICAL COLLEGE
|
TN
|
$27,378
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NIAID
|
5F32AI114132-02
|
|
The essential role of gamma-secretase in human papillomavirus infection
|
ZHANG, WEI
|
YALE UNIVERSITY
|
CT
|
$54,194
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5K22CA186979-02
|
|
Improving Healthcare Providers' Communication about HPV Vaccine
|
GILKEY, MELISSA
|
HARVARD PILGRIM HEALTH CARE, INC.
|
MA
|
$187,212
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5K01CA181530-02
|
|
Determinants of HPV vaccination for Hispanic parents from the Texas-Mexico border
|
MORALES-CAMPOS, DAISY
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
TX
|
$96,020
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5R01CA178875-02
|
|
Influencing cervical cancer prevention and detection online through social media
|
SARKAR, URMIMALA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
CA
|
$428,238
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5P50CA098252-12
|
5957
|
L1 Capsomeres as a Next Generation Preventive HPV Vaccine
|
GARCEA, ROBERT
|
UNIVERSITY OF COLORADO
|
CO
|
$244,159
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5P50CA098252-12
|
5958
|
Local TA-CIN/GPI-0100 Vaccination and Imiquimod for Persistent HPV16+/Normal Cytology Patients
|
RODEN, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$243,724
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5P50CA098252-12
|
5959
|
Treatment of HIV- and HIV+ Patients with HPV16+ CIN2/3 Using pNGLV4a-hCRTE6E7L2 DNA vaccine administered intramuscularly via electroporation
|
HUNG, CHIEN-FU
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$243,724
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
5P50CA098252-12
|
5961
|
A Phase I Safety and Immunogenicity Study of a HPV16-Specific Therapeutic Protei
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$240,679
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
1R03CA198115-01
|
|
HPV Infection among Sexual Minority Women in the United States
|
REITER, PAUL
|
OHIO STATE UNIVERSITY
|
OH
|
$77,000
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
1U01CA199334-01
|
|
Comparative Modeling to Inform Cervical Cancer Control Policies
|
KIM, JANE
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
MA
|
$1,212,678
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
7R01CA166559-04
|
|
Quadrivalent Human Papillomavirus (HPV) Vaccine in Cancer Survivors
|
LANDIER, WENDY
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$551,166
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
3R01CA178414-03S1
|
|
Developing a self-persuasion intervention promoting adolescent HPV vaccination
|
TIRO, JASMIN
|
UT SOUTHWESTERN MEDICAL CENTER
|
TX
|
$54,055
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
2U54CA143728-06A1
|
6846
|
Outreach Core
|
SOMERA, LILNABETH
|
UNIVERSITY OF GUAM
|
GU
|
$72,468
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
2U54CA143727-06A1
|
7018
|
Outreach Core
|
PALAFOX, NEAL
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$108,944
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
FIC
|
3D43TW009606-03S1
|
|
Haiti Research Training Program in the Prevention of AIDS Cervical Cancer
|
FITZGERALD, DANIEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
NY
|
$54,000
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
3U54CA153708-05S1
|
|
Meharry Medical College-CHC Community Networks Program Center
|
HARGREAVES, MARGARET
|
MEHARRY MEDICAL COLLEGE
|
TN
|
$373,140
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
6U01CA078527-18
|
|
Persistent HPV Infection in Women at Risk for Cervix Cancer
|
BURK, ROBERT
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
NY
|
$581,591
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NIAID
|
1R56AI122000-01
|
|
Application of a syndemic framework to HPV and HSV infection in emergent adult men
|
OMPAD, DANIELLE
|
NEW YORK UNIVERSITY
|
NY
|
$583,635
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
6R01CA148966-06
|
|
Expanded Phase II Trial of Carraguard for Prevention of HPV Infection
|
EINSTEIN, MARK
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
NY
|
$1
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NICHD
|
1ZIAHD008900-06
|
|
Safety and Immunogenicity of Gardasil post stem cell transplantation
|
STRATTON, PAMELA
|
NIH
|
|
$223,235
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NIAID
|
272201200005I-0-27200009-1
|
|
Task X9: Agilvax Phage Display for Multiple Vaccine Candidates
|
RICHARDSON, JAMES
|
ADVANCED BIOSCIENCE LABORATORIES, INC.
|
MD
|
$1,505,999
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NIAID
|
272201200005I-0-27200013-2
|
|
Task X13: Product Characterization and Process Development
|
RICHARDSON, JAMES
|
ADVANCED BIOSCIENCE LABORATORIES, INC.
|
MD
|
$203,071
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NIAID
|
272201200005I-0-27200010-1
|
|
Task X10: Cell Bank Work for Agilvax
|
RICHARDSON, JAMES
|
ADVANCED BIOSCIENCE LABORATORIES, INC.
|
MD
|
$391,378
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
1ZIABC009052-26
|
|
Papillomavirus Virion Proteins and Vaccines
|
SCHILLER, JOHN
|
NIH
|
|
$2,058,212
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
1ZIABC010579-12
|
|
Papillomavirus Virion Proteins and Vaccines
|
LOWY, DOUGLAS
|
NIH
|
|
$754,666
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
1ZIACP010124-20
|
|
Human papillomavirus (HPV) infection and cervical and anal cancers
|
WENTZENSEN, NICOLAS
|
NIH
|
|
$747,917
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
1ZIACP010209-06
|
|
HPV and cancer at multiple anatomic sites
|
KREIMER, AIMEE
|
NIH
|
|
$617,212
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
1ZIACP010210-06
|
|
HPV, cervical neoplasia, and vaccination
|
HILDESHEIM, ALLAN
|
NIH
|
|
$130,164
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
1ZIACP010216-06
|
|
Immune responses to HPV infection and HPV vaccination
|
SAFAEIAN, MAHBOOBEH
|
NIH
|
|
$1,132,580
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
1ZIACP010217-05
|
|
HPV Vaccine Trial
|
HILDESHEIM, ALLAN
|
NIH
|
|
$3,033,861
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
261201500026I-0-26100002-1
|
|
IGF::OT::IGF SUPPORT FOR HPV16L1/RG1 CHIMERIC VIRUS-LIKE PARTICLE VACCINE CLINICAL DEVELOPMENT TASKS 1&2 PP: 9/25/2015 TO 9/24/2018
|
LYUBIMOV, ALEXANDER
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$1,325,083
|
|
HPV and/or Cervical Cancer Vaccines
|
2015
|
NCI
|
261201200031I-0-26100009-1
|
|
IGF::OT::IGF - A PROSPECTIVE, SINGLE-ARM, OPEN-LABEL, NON-RANDOMIZED, PHASE IIA TRIAL OF A NONAVALENT PROPHYLACTIC HPV VACCINE TO ASSESS IMMUNOGENICITY OF A PRIME AND DEFERRED-BOOSTER DOSING SCHEDULE
|
CHOW, SHERRY
|
NIH
|
|
$1,159,640
|
